Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 6/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6408823 | 0.99 | MEN1 (0.43) | MEN1KMT2APOLBALDH1A1L3MBTL1 | |
| SCHEMBL6415606 | 0.93 | MEN1 (0.39) | MEN1KMT2APOLBALDH1A1CCR5 | |
| SCHEMBL6414737 | 0.93 | CCR5 (0.41) | MEN1KMT2APOLBALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL6415599 | 0.92 | MEN1 (0.39) | MEN1KMT2APOLBALDH1A1CCR5 | |
| SCHEMBL6435174 | 0.92 | MEN1 (0.40) | MEN1KMT2APOLBALDH1A1ROCK2 | |
| Hydrochloric Acid SCHEMBL6414732 | 0.92 | CCR5 (0.40) | MEN1KMT2APOLBALDH1A1L3MBTL1 | |
| SCHEMBL6411551 | 0.91 | ROCK2 (0.44) | MEN1KMT2APOLBALDH1A1L3MBTL1 | |
| SCHEMBL6412947 | 0.91 | CCR5 (0.39) | MEN1KMT2APOLBALDH1A1CCR5 | |
| Hydrochloric Acid SCHEMBL6411547 | 0.91 | ROCK2 (0.44) | MEN1KMT2APOLBALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL6412939 | 0.90 | CCR5 (0.39) | MEN1KMT2APOLBALDH1A1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050075326-A1 | Spiro compounds and methods for the modulation of chemokine receptor activity | VIROCHEM PHARMA INC (CA) | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075326-A1 | Spiro compounds and methods for the modulation of chemokine receptor activity | CXCR1, CXCR4, CXCR2 | MEN1 4007/4885KMT2A 4587/4885POLB 3564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.